Wettig Thane's Form 4/A amendment
AmendedKyntra Bio, Inc. (KYNB) · filed Jun 22, 2023
- Accession no.
- 0001209191-23-039157
- Filed
- Jun 22, 2023
- Trade date
- Jun 7, 2023
- Filing delay
- 15 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jun 9, 2023
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $30.0K. It was filed 15 days after the trade.
This amendment replaces 0001209191-23-036066 (filed Jun 9, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wettig ThaneCIK 0001815638 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2023 | Common Stock | SSaleDisposed | −472 | $17.04 | −$8,042.88 | 110,338 | Direct | |
| Jun 7, 2023 | Common Stock | SSaleDisposed | −1,286 | $17.04 | −$21,913.44 | 109,052 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.